Inhibiting GLS1, either by knockdown or with the drug CB‐839, reduces OXPHOS, arrests leukemic cell proliferation, and induces apoptosis without affecting normal progenitors, significantly inhibiting AML development in mice [9]. This evidence concerns the gene GLS and acute myeloid leukemia.